Thandra K C, Barsouk A, Saginala K, et al. Epidemiology of lung cancer[J]. Contemp Oncol(Pozn), 2021,25(1):45-52.
[2]
Zheng R S, Chen R, Han B F, et al.[Cancer incidence and mortality in China, 2022][J]. Zhonghua Zhong Liu Za Zhi, 2024,46(3):221-231.
[3]
Kumar N R, Premalatha K, Suvitha S. Lung disease detection using Self-Attention Generative Adversarial Capsule network optimized with sun flower Optimization Algorithm[J]. Biomedical Signal Processing and Control, 2023,79(1746-8094):104241.
[4]
Li W, Feng S, Wu H, et al. Comprehensive analysis of CDK1-associated ceRNA network revealing the key pathways LINC00460/LINC00525-Hsa-Mir-338-FAM11 1/ZWINT as prognostic biomarkers in lung adenocarcinoma combined with experiments[J]. Cells, 2022,11(2073-4409):1220.
[5]
Jakopovic M, Brcic L, Miic M, et al. Rates of EGFR, KRAS and ALK gene changes in lung cancer patients in Croatia[J]. J Clin Oncol, 2016,34(0732-183X):e23238.
[6]
Wang S, Young M J, Wang Y C, et al. USP24 promotes drug resistance during cancer therapy[J]. Cell Death & Differentiation, 2021,28(1350-9047):2690-2707.
[7]
Gao W, Wen C P, Wu A, et al. Association of computed tomographic screening promotion with lung cancer overdiagnosis among asian women[J]. JAMA Intern Med, 2022,182(3):283-290.
[8]
Duan J, Zhong B, Fan Z, et al. DNA methylation in pulmonary fibrosis and lung cancer[J]. Expert Rev Respir Med, 2022,16(5):519-528.
[9]
Liu T, Guo W, Luo K, et al. Smoke-induced SAV1 Gene Promoter hypermethylation disrupts YAP negative feedback and promotes malignant progression of non-small cell lung cancer[J]. Int J Biol Sci, 2022,18(11):4497-4512.
[10]
Zhang Z, Li J, Liu H, et al. Impact of systemic immune-inflammation index in patients with limited-stage small cell lung cancer[J]. J Clin Oncol, 2023,41(0732-183X):e20626.
Zhang X, Qiu H, Li C, et al. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer[J]. Biosci Trends, 2021,15(5):283-298.
[14]
Maiga A W, Deppen S A, Denton J, et al. Uptake of video-assisted thoracoscopic lung resections within the veterans affairs for known or suspected lung cancer[J]. JAMA Surg, 2019,154(6):524-529.
[15]
Zhang F, Xu L, Lu H, et al. Short-term surgical outcomes for lobectomy between robot-assisted thoracic surgery and uniportal video-assisted thoracoscopic surgery[J]. Front Oncol, 2022,12:914059.
[16]
Bertolaccini L, Casiraghi M, Uslenghi C, et al. Advances in lung cancer surgery: the role of segmentectomy in early-stage management[J]. Expert Review of Respiratory Med, 2024,10(1747-6348):1-7.
[17]
Cai H, Wang Y, Qin D, et al. Advanced surgical technologies for lung cancer treatment: Current status and perspectives[J]. Engineered Regeneration, 2023,4(2666-1381):55-67.
Zhao X, Dai X, Wang S, et al. Traditional Chinese medicine integrated with chemotherapy for stage Ⅱ-ⅢA Patients with non-small-cell lung cancer after radical surgery: a retrospective clinical analysis with small sample size[J]. Evidence-based Complementary and Alternative Medicine, 2018,2018(1741-427X):1-7.
[23]
Navarro-Martin A, Galiana I L, Berenguer F M, et al. Preliminary study of the effect of stereotactic body radiotherapy(SBRT) on the immune system in lung cancer patients unfit for surgery: immunophenotyping analysis[J]. Int J Mol Sci, 2018,19(12).
[24]
Timmerman R D, Paulus R, Pass H I, et al. Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 Trial[J]. JAMA Oncol, 2018,4(9):1263-1266.
Zhu X. Clinical effect of auricular point sticking in patients with lung cancer receiving chemotherapy[J]. Proceedings of Anticancer Research, 2021,5(2208-3545):73-77.
[31]
Abuarab S F, Talib W H. Immunomodulatory and anticancer activities of barley bran grown in jordan: an in vitro and in vivo study[J]. Frontiers in Nutrition, 2022,9(2296-861X):0-0.
[32]
Aikins M E, Xu C, Moon J J. Engineered nanoparticles for cancer vaccination and immunotherapy[J]. Acc Chem Res, 2020,53(10):2094-2105.
[33]
Fenis A, Demaria O, Gauthier L, et al. New immune cell engagers for cancer immunotherapy[J]. Nature Reviews Immunology, 2024,0(1474-1733):0-0.
[34]
Wang X, Barrera C, Bera K, et al. Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes(TILs) predict clinical benefit for immune checkpoint inhibitors[J]. Science Advances, 2022,8(2375-2548):0-0.
[35]
Wang Y, Zhang H. FAT10 is a prognostic biomarker and correlated with immune infiltrates in skin cutaneous melanoma[J]. Front Mol Biosci, 2022,9:805887.
[36]
Wang F, Xia T, Liu Z, et al. Current status of clinical trial research and application of immune checkpoint inhibitors for non-small cell lung cancer[J]. Frontiers in Oncology, 2023,13(2234-943X):100.
Wei Z, Chen J, Zuo F, et al. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: a review[J]. J Ethnopharmacol, 2023,300:115748.
[43]
Li C, Niu M, Wang R, et al. The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach[J]. Biomed Pharmacother, 2019,111:1132-1140.
[44]
Zhang Y, Yao Y, Fu Y, et al. Inhibition effect of oxyepiberberine isolated from coptis chinensis franch. on non-small cell lung cancer based on a network pharmacology approach and experimental validation[J]. Journal of Ethnopharmacology, 2021,278:114267.
2025, Vol. 36 
